Caricamento...
The steady progress of targeted therapies, promising advances for lung cancer
Lung cancer remains one of the most complex and challenging cancers, being responsible for almost a third of all cancer deaths. This grim picture seems however to be changing, for at least a subset of lung cancers. The number of patients who can benefit from targeted therapies is steadily increasing...
Salvato in:
| Pubblicato in: | Ecancermedicalscience |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Cancer Intelligence
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4898931/ https://ncbi.nlm.nih.gov/pubmed/27350784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.638 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|